8-K - NRx Pharmaceuticals, Inc. | StockGist

Current Report Details

Event Type

Auditor Change

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

4.01

Changes in Registrant ’ s Certifying Accountant. Engagement of New Independent Registered Public Accounting Firm and Dismissal of Independent Registered Public

Auditor Change

9.01

. Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 16.1* Letter from Salberg & Company P.A. to the SEC dated November 25, 2025. 104 Co

Exhibits Only

Exhibits (2)

16.1

EXHIBIT 16.1

8-K

FORM 8-K